-
Allergan's Chief R&D Officer Talks Avycaz, Assembly Biosciences And 6 'Potential Blockbusters' In The Pipeline
Monday, February 13, 2017 - 4:13pm | 718Early Monday, Allergan plc Ordinary Shares (NYSE: AGN) — one of the world's largest pharmaceutical companies that produces branded and generic drugs, and performs pharmaceutical research and development — announced its recent acquisition of Zeltiq Aesthetics. Benzinga had the privilege...